Antifungal Stewardship Interventions in Patients with Hematologic Malignancies

被引:3
|
作者
Vergidis, Paschalis [1 ]
Stevens, Ryan W. [2 ]
Agrawal, Samir G. [3 ,4 ]
机构
[1] Mayo Clin, Div Publ Hlth, Infect Dis & Occupat Med Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Dept Pharm, Rochester, MN USA
[3] St Bartholomews Hosp, Dept Haemato Oncol, London EC1A 7BE, England
[4] Queen Mary Univ London, Blizard Inst, Fac Med & Dent, London, England
关键词
Antifungal stewardship; Hematology candidiasis; Aspergillosis; Guidelines; Metrics; INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; ANTIMICROBIAL STEWARDSHIP; PRACTICE GUIDELINES; 2016; UPDATE; MANAGEMENT; PROGRAM; DIAGNOSIS; RECOMMENDATIONS; ASPERGILLOSIS;
D O I
10.1007/s12281-023-00465-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of ReviewAntifungal stewardship has been recognized as a significant component of any antimicrobial stewardship program. In this article, we aim to provide a review of recommendations and antifungal stewardship interventions in hematologic patients.Recent FindingsCore elements of antibiotic stewardship programs can be applied to antifungal stewardship practices. Engagement of high-prescribing specialists, timely access to fungal diagnostics, screening for drug-drug interactions, and therapeutic drug monitoring are recommended practices that specifically pertain to antifungal stewardship. Tools recently developed in assessing adherence to guidelines can prove useful in evaluating prescribing practices. The most common longitudinal metrics are likely to hinge on measuring antifungal consumption. However, many of the parameters to measure antifungal stewardship activity and performance are extremely challenging to obtain.A multifaceted antifungal stewardship approach is required to improve antifungal use among hematologic patients in an efficient and sustainable manner.
引用
收藏
页码:108 / 118
页数:11
相关论文
共 50 条
  • [21] Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy
    Amanati, Ali
    Badiee, Parisa
    Jafarian, Hadis
    Ghasemi, Fatemeh
    Nematolahi, Samane
    Haghpanah, Sezaneh
    Hamzavi, Seyedeh Sedigheh
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] STRONGYLOIDIASIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    NUCCI, M
    PORTUGAL, R
    PULCHERI, W
    SPECTOR, N
    FERREIRA, SB
    DECASTRO, MB
    NOE, R
    DEOLIVEIRA, HP
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) : 675 - 677
  • [23] CRYPTOSPORIDIOSIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    GENTILE, G
    VENDITTI, M
    MICOZZI, A
    CAPRIOLI, A
    DONELLI, G
    TIRINDELLI, C
    MELONI, G
    ARCESE, W
    MARTINO, P
    REVIEWS OF INFECTIOUS DISEASES, 1991, 13 (05): : 842 - 846
  • [24] Hyperglycemia in Patients with Hematologic Malignancies
    Healy, Sara J.
    Dungan, Kathleen M.
    CURRENT DIABETES REPORTS, 2015, 15 (03)
  • [25] Angiogenesis in patients with hematologic malignancies
    Mesters, RM
    Padró, T
    Steins, M
    Bieker, R
    Retzlaff, S
    Kessler, T
    Kienast, J
    Berdel, WE
    ONKOLOGIE, 2001, 24 : 75 - 80
  • [26] Hyperglycemia in Patients with Hematologic Malignancies
    Sara J. Healy
    Kathleen M. Dungan
    Current Diabetes Reports, 2015, 15
  • [27] Bacteremia in patients with hematologic malignancies
    Wang, FD
    Liu, YM
    Liu, CY
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (06) : 405 - 409
  • [28] Hematologic malignancies in elderly patients
    Hassan, Moustapha
    Abedi-Valugerdi, Manuchehr
    HAEMATOLOGICA, 2014, 99 (07) : 1124 - 1127
  • [29] Cholecystectomy in patients with hematologic malignancies
    Stewart, Camille L.
    Tran, Thuy B.
    Nguyen, Andrew
    Zain, Jasmine
    Lai, Lily
    Fong, Yuman
    Woo, Yanghee
    AMERICAN JOURNAL OF SURGERY, 2022, 223 (06): : 1157 - 1161
  • [30] Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary
    Su, Christopher T.
    JCO ONCOLOGY PRACTICE, 2022, 18 (09) : 607 - +